QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=2766B9A4379564671E9BCB65AB596CAF;jsessionid=A06FF884E94C89B37D11661C0B1FCC3D;jsessionid=C9D3C0005C04116F11F9144A1B30FB1B;jsessionid=FC7A42C6408FDA2AD53FE68669585523;jsessionid=07EA2EF549E8C40EC52EE21DD1B2B51E;jsessionid=A4AA542CB45B67E8DD1582586524B82D;jsessionid=2ED0B27D4F3B8DB9C3F9CF43F6B0C9D6;jsessionid=D240867D412E196EEAE4B4986644E11A;jsessionid=FC8DDEFCCA38833F2D065D4337EB3E02 (gene)

1. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…
2. Routine betamethasone therapy of non-hydropic fetuses with CPAM - the way to improve perinatal outco…
3. Endoscopic Interventions in Pancreatic Cystic Neoplasms.
4. Surveillance of Pancreatic Cystic Neoplasms.
5. Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=2766B9A4379564671E9BCB65AB596CAF;jsessionid=A06FF884E94C89B37D11661C0B1FCC3D;jsessionid=C9D3C0005C04116F11F9144A1B30FB1B;jsessionid=FC7A42C6408FDA2AD53FE68669585523;jsessionid=07EA2EF549E8C40EC52EE21DD1B2B51E;jsessionid=A4AA542CB45B67E8DD1582586524B82D;jsessionid=2ED0B27D4F3B8DB9C3F9CF43F6B0C9D6;jsessionid=D240867D412E196EEAE4B4986644E11A;jsessionid=FC8DDEFCCA38833F2D065D4337EB3E02